189 related articles for article (PubMed ID: 30439987)
1. Respiratory syncytial virus hospitalization in children in northern Spain.
Viguria N; Martínez-Baz I; Moreno-Galarraga L; Sierrasesúmaga L; Salcedo B; Castilla J
PLoS One; 2018; 13(11):e0206474. PubMed ID: 30439987
[TBL] [Abstract][Full Text] [Related]
2. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
Simoes EA; Carbonell-Estrany X
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
[TBL] [Abstract][Full Text] [Related]
4. Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.
Fortunato F; Campanozzi A; Maffei G; Arena F; Carri VD; Rollo T; Lopalco PL; Martinelli D
Ital J Pediatr; 2024 Mar; 50(1):45. PubMed ID: 38454523
[TBL] [Abstract][Full Text] [Related]
5. Respiratory syncytial virus-associated hospitalizations over three consecutive seasons in children with congenital heart disease.
Resch B; Kurath-Koller S; Hahn J; Raith W; Köstenberger M; Gamillscheg A
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1165-9. PubMed ID: 27126331
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic.
Winthrop ZA; Perez JM; Staffa SJ; McManus ML; Duvall MG
JAMA Netw Open; 2024 Jun; 7(6):e2416852. PubMed ID: 38869896
[TBL] [Abstract][Full Text] [Related]
7. SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
Anderson EJ; DeVincenzo JP; Simões EAF; Krilov LR; Forbes ML; Pannaraj PS; Espinosa CM; Welliver RC; Wolkoff LI; Yogev R; Checchia PA; Domachowske JB; Halasa N; McBride SJ; Kumar VR; McLaurin KK; Rizzo CP; Ambrose CS
Am J Perinatol; 2020 Mar; 37(4):421-429. PubMed ID: 30991438
[TBL] [Abstract][Full Text] [Related]
8. Respiratory Syncytial Virus Bronchiolitis in Children up to 5 Years of Age in Spain: Epidemiology and Comorbidities: An Observational Study.
Gil-Prieto R; Gonzalez-Escalada A; Marín-García P; Gallardo-Pino C; Gil-de-Miguel A
Medicine (Baltimore); 2015 May; 94(21):e831. PubMed ID: 26020386
[TBL] [Abstract][Full Text] [Related]
9. The contribution of child, family and health service factors to respiratory syncytial virus (RSV) hospital admissions in the first 3 years of life: birth cohort study in Scotland, 2009 to 2015.
Hardelid P; Verfuerden M; McMenamin J; Smyth RL; Gilbert R
Euro Surveill; 2019 Jan; 24(1):. PubMed ID: 30621817
[TBL] [Abstract][Full Text] [Related]
10. Pediatric intensive care unit admission due to respiratory syncytial virus: Retrospective multicenter study.
Kang JM; Lee J; Kim YK; Cho HK; Park SE; Kim KH; Kim MJ; Kim S; Kim YJ
Pediatr Int; 2019 Jul; 61(7):688-696. PubMed ID: 31107995
[TBL] [Abstract][Full Text] [Related]
11. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus morbidity, premorbid factors, seasonality, and implications for prophylaxis.
Hon KL; Leung TF; Cheng WY; Ko NM; Tang WK; Wong WW; Yeung WH; Chan PK
J Crit Care; 2012 Oct; 27(5):464-8. PubMed ID: 22227087
[TBL] [Abstract][Full Text] [Related]
13. Palivizumab prophylaxis of respiratory syncytial virus disease from 1998 to 2002: results from four years of palivizumab usage.
Romero JR
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S46-54. PubMed ID: 12671452
[TBL] [Abstract][Full Text] [Related]
14. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
15. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
[TBL] [Abstract][Full Text] [Related]
16. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study.
Ares-Gómez S; Mallah N; Pardo-Seco J; Malvar-Pintos A; Pérez-Martínez O; Otero-Barrós MT; Súarez-Gaiche N; Santiago-Pérez MI; González-Pérez JM; López-Pérez LR; Rosón B; Alvárez-Gil RM; Ces-Ozores OM; Nartallo-Penas V; Mirás-Carballal S; Rodríguez-Tenreiro C; Rivero-Calle I; Salas A; Durán-Parrondo C; Martinón-Torres F
Pediatr Allergy Immunol; 2024 May; 35(5):e14131. PubMed ID: 38700124
[TBL] [Abstract][Full Text] [Related]
17. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born at a gestational age of 33-35 weeks in Spain.
Figueras-Aloy J; Carbonell-Estrany X; Quero J;
Pediatr Infect Dis J; 2004 Sep; 23(9):815-20. PubMed ID: 15361718
[TBL] [Abstract][Full Text] [Related]
18. Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018.
Demont C; Petrica N; Bardoulat I; Duret S; Watier L; Chosidow A; Lorrot M; Kieffer A; Lemaitre M
BMC Infect Dis; 2021 Aug; 21(1):730. PubMed ID: 34340679
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors for Respiratory Syncytial Virus Infections in Moderate/Late Premature Infants in Turkey: A Prospective Multicenter Epidemiological Study.
Ozkan H; Celebi S; Koksal N; Hacımustafaoğlu M; Koc E; Tezer H; Cetinkaya M; Cebeci B; Erdeve O; Ozdemir H;
Am J Perinatol; 2021 Dec; 38(14):1540-1546. PubMed ID: 32659789
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.
Loubet P; Lenzi N; Valette M; Foulongne V; Krivine A; Houhou N; Lagathu G; Rogez S; Alain S; Duval X; Galtier F; Postil D; Tattevin P; Vanhems P; Carrat F; Lina B; Launay O;
Clin Microbiol Infect; 2017 Apr; 23(4):253-259. PubMed ID: 27903461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
